Table 2 32 TCGA cancer types used in this study
From: Correlate tumor mutation burden with immune signatures in human cancers
Cancer | Full name | # cancer samples c | # normal samples | # higher-TMB samples | # lower-TMB samples |
|---|---|---|---|---|---|
ACC | adrenocortical carcinoma | 79 | 0 | 16 | 20 |
BLCA | bladder urothelial carcinoma | 408 | 19 | 99 | 97 |
BRCA | breast invasive carcinoma | 1100 | 112 | 241 | 245 |
CESC | cervical squamous-cell carcinoma and endocervical adeno-carcinoma | 306 | 3 | 50 | 46 |
CHOL | cholangiocarcinoma | 36 | 9 | 9 | 9 |
COAD | colon adenocarcinoma | 287 | 41 | 53 | 49 |
DLBC | lymphoid neoplasm diffuse large B-cell lymphoma | 48 | 0 | 12 | 12 |
ESCA | esophageal carcinoma | 185 | 11 | 45 | 46 |
GBM | glioblastoma multiforme | 166 | 5 | 41 | 30 |
HNSC | head and neck squamous cell carcinoma | 522 | 44 | 127 | 123 |
KICH | kidney chromophobe | 66 | 25 | 17 | 17 |
KIRC | kidney renal clear cell carcinoma | 534 | 72 | 120 | 110 |
KIRP | kidney renal papillary cell carcinoma | 291 | 32 | 70 | 68 |
LAML | acute myeloid leukemia | 173 | 0 | 24 | 24 |
LGG | brain lower-grade glioma | 530 | 0 | 69 | 66 |
LIHC | liver hepatocellular carcinoma | 373 | 50 | 90 | 87 |
LUAD | lung adenocarcinoma | 517 | 59 | 120 | 127 |
LUSC | lung squamous cell carcinoma | 501 | 51 | 45 | 45 |
OV | ovarian serous cystadeno-carcinoma | 307 | 0 | 29 | 22 |
PAAD | pancreatic adeno-carcinoma | 179 | 4 | 46 | 38 |
PCPG | pheochromocytoma and paraganglioma | 184 | 3 | 45 | 41 |
PRAD | prostate adenocarcinoma | 498 | 52 | 119 | 113 |
READ | rectum adenocarcinoma | 95 | 10 | 19 | 20 |
SARC | sarcoma | 263 | 2 | 63 | 64 |
SKCM | skincutaneous melanoma | 472 | 1 | 117 | 118 |
STAD | stomach adenocarcinoma | 415 | 35 | 90 | 85 |
TGCT | testicular germ-cell tumors | 156 | 0 | 39 | 35 |
THCA | thyroid carcinoma | 509 | 59 | 122 | 108 |
THYM | thymoma | 120 | 2 | 29 | 29 |
UCEC | uterine corpus endometrial carcinoma | 370 | 11 | 59 | 60 |
UCS | uterine carcino-sarcoma | 57 | 0 | 14 | 13 |
UVM | uveal melanoma | 80 | 0 | 20 | 19 |